Loading...
Lentiviral Vector Platform for Production of Bioengineered Recombinant Coagulation Factor VIII
Patients with hemophilia A present with spontaneous and sometimes life-threatening bleeding episodes that are treated using blood coagulation factor VIII (fVIII) replacement products. Although effective, these products have limited availability worldwide due to supply limitations and product costs,...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3034847/ https://ncbi.nlm.nih.gov/pubmed/21081907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2010.239 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|